Drug makers see new wave in multiple sclerosis care - Boston Globe

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service89 times read : Adjust font size: Decrease font Enlarge font
image

SAN FRANCISCO - The first in a new wave of multiple sclerosis medicines, from drug makers led by Novartis AG and Merck KGaA, may reach the market next year, making therapy more convenient for patients and boosting profits. In Seattle this week, the ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright